Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001172661-25-000879·Deep Track Capital, LP
Schedule 13G ownership disclosure
SPRINGWORKS THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 85205L107
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 3,460,756.00 · Class: 4.65%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 3,460,756.00 · Class: 4.65%
- David Kroin
Shares: 3,460,756.00 · Class: 4.65%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-000879
- Form type
- SCHEDULE 13G/A
- Filer
- Deep Track Capital, LP
- CIK
- CIK 1856083
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership